cocaine (coc)-and cocaethylene (CE)-creatinine clearance ratios (CCR) were determined in five patients. In each case, COC:CCR greatly exceeded C/.'CCR, and in four patients the data suggested renal tubular secretion of COC. For all patients, some renal tubular reabsorption of CE was apparent. These findings may be due, at least in part, to the greater hydrophobicity of CE relative to COC and to the lower pKb of CE (8.23) than that of COC (8.60). The pKb of CE was determined by tltrimetry and is reported here for the first time. These data may be useful in investigating the pharmacokinetic profiles of COC and CE in humans and may also help to explain the longer plasma half-life of CF relative to that of COC.
Introduction
Cocaethylene (CE) is a pharmacologically important transesterification product of cocaine (COC) and ethanol (ETOH) that is formed when they are ingested together (1, 2) . Like COC, CE binds to the dopamine transporter and inhibits the uptake of dopamine into synaptosomes (1, 2) . The behavioral pharmacology of CE is similar to that of COC, and both compounds produce essentially the same psychomotor stimulant effects, although COC is more potent in this regard (1, 3) . The enzyme responsible for this reaction has been purified and characterized as a hepatic carboxylesterase that, in the absence of ETOH, catalyzes the production of benzoylecgonine, the major metabolite of COC in urine (4) . The toxicity of CE is greater than that of COC, and its LDs0 is considerably lower (5). The plasma half-life of CE is also longer than that of COC, which makes CE toxicologically important in humans (6) .
The concept of analyte-creatinine clearance ratios (CCR) is familiar to most clinical laboratory workers and has generally been used to estimate renal tubular secretion versus reabsorption of compounds, most notably amylase (7) (8) (9) .
In an attempt to explain the longer plasma half-life of CE relative to that of COC, the COC:CCR and CE:CCR ratios were investigated in five patients. The findings were correlated with the relative hydrophobicity of each drug and to the PKb (PKa for basic drugs) of each drug. The PKb of CE is reported here for the first time.
Experimental

Patients and Samples
Five patients admitted to the University of California, San Diego (UCSD) Medical Center were included in this study. Blood and urine samples from each patient were submitted to the UCSD Medical Center Clinical Toxicology Laboratory for drug screening for purposes of patient care, and CE was discovered in each patient by thin-layer chromatography of urine (10) . Whole blood, anticoagulated with potassium oxalate and preserved with sodium fluoride, was submitted for alcohol analysis. Urine was submitted for drug screening, and serum was provided for additional toxicology studies. All specimens were collected at the time of the admission of the patient to the hospital, and no specimens were obtained specifically for the purposes of this study. Residual fluoride-preserved plasma and urine were used for analysis of COC and CE, whereas residual serum and urine were used for measurement of creatinine (CR). Plasma and urine samples were frozen (-20~ until the time of analysis, which ranged from three to eight weeks from the time of sample collection. Previous work demonstrated the stability of COC and its metabolites in blood and urine under these storage conditions for more than 100 days (11, 12) .
Drug screening
Whole blood was analyzed for alcohols by flame-ionization gas-liquid chromatography after dilution with aqueous n-propranol as the internal standard (13) . Urine was analyzed for drugs of abuse by various thin-layer chromatographic, immunoassay, spectroscopic, and gas-liquid chromatographic methods previously described (10, 14) .
Measurement of COC and CE
Both COC and CE were measured in residual fluoridated plasma and in residual urine (diluted appropriately) using high-pressure liquid chromatography with a IN detector and the n-propyl analogue of COC, cocapropylene, as the internal standard (15) . Reference calibrators in drug-free plasma and in water were prepared from COC hydrochloride (Merck, Rahway, NJ) and from CE base (Sigma Chemical, St. Louis, MO). The calibrators were analyzed concurrently with the patient samples and were used for quantitation of the concentrations in each sample.
Analysis of CR
Measurement of CR in residual serum and residual urine was performed on a Beckman CX7 automated analyzer (Beckman Instruments, Fullerton, CA).
Calculation of CCR
Both COC:CCR and CE:CCR were calculated by the following formula (7-9):
It should be noted that urine flow rates are not included because the same urine sample is used for COC or CE clearance and for CR clearance, and the values would cancel one another out. Hence, random (nontimed) urine samples can be used. However, use of random urine specimens precludes the calculation of individual clearance ratios for COC and CE. 
Results
The age, gender, and toxicologic findings for each of the five patients are shown in Table I . The concentrations of COC, CE, and CR in plasma or serum and in urine are shown in Table II 
Discussion
For all five patients, COC:CCR greatly exceeded CE:CCR (Table II) . Also, in each case, some renal tubular reabsorption of CE was apparent because all CE:CCR were less than 100%. In four instances (patients 1, 2, 3, and 5), COC:CCR was more than 100%, which suggests the renal tubular secretion of COC. The presence of normal serum creatinine in all five patients (Table [I) suggested normal renal function, which indicates that renal insufficiency did not contribute to the findings. Because all urines studied were acidic (pH 5-6) (Table II) , these findings may be due to the demonstrated PKb of CE (8.23), which was lower than that of COC, which was reported to be 8.60 when determined under similar analytical conditions (17, 18) . At urinary pH, CE would be less ionized (and thus more reabsorbed) than COC. Conversely, because COC would be more ionized at urinary pH, it would be more likely to be secreted. In addition, the longer (ethyl) ester side chain present in CE should make it more hydrophobic (and hence more susceptible to reabsorption) than COC, which has a methyl ester side chain. On the other hand, the shorter (methyl) ester side chain of COC should make it more water soluble (and hence more susceptible to secretion) than the ethyl homologue, CE.
Conclusion
Although this is a small series that may not be representative of the population at large, the findings may nonetheless be useful in investigating the pharmacokinetic profiles of COC and CE in humans. They may also help to explain the observed longer plasma half-life of CE relative to that of COC (6) .Finally, it is conceivable that the enzymatic degradation of CE may occur at a rate slower than that of COC, although this has not been reported.
